Published in Kidney Int Suppl on May 01, 1998
Renal blood flow in sepsis. Crit Care (2005) 1.59
The histopathology of septic acute kidney injury: a systematic review. Crit Care (2008) 1.43
Influence of fluid resuscitation on renal microvascular PO2 in a normotensive rat model of endotoxemia. Crit Care (2006) 0.92
Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure. Crit Care (2003) 0.88
Genetic polymorphisms and risk for acute renal failure in preterm neonates. Pediatr Nephrol (2004) 0.83
The effect of bortezomib on expression of inflammatory cytokines and survival in a murine sepsis model induced by cecal ligation and puncture. Yonsei Med J (2015) 0.77
Impairment of neutrophilic glucocorticoid receptor function in patients treated with steroids for septic shock. Intensive Care Med Exp (2015) 0.77
Diuretics induced uremia and nonrecovery of renal function in a patient with acute renal failure caused by sepsis. Indian J Pharmacol (2011) 0.75
Biopsy series of acute kidney injury from a tertiary care referral center in south India. J Nephropharmacol (2015) 0.75
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med (1996) 35.00
Increased plasma levels of interleukin-6 in sepsis. Blood (1989) 3.92
Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet (1998) 2.84
Hypernatremia in the intensive care unit: an indicator of quality of care? Crit Care Med (1999) 2.33
Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis. Intensive Care Med (1998) 2.12
Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun (1992) 1.85
Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis. J Lab Clin Med (1992) 1.65
Transvascular transport of 67Ga in the lungs after cardiopulmonary bypass surgery. Chest (1993) 1.64
C1-esterase inhibitor substitution in sepsis. Lancet (1992) 1.61
Prediction of mortality in febrile medical patients: How useful are systemic inflammatory response syndrome and sepsis criteria? Chest (1998) 1.61
Role of cytokines in sepsis. Adv Immunol (1997) 1.60
Continuous cardiac output in septic shock by simulating a model of the aortic input impedance: a comparison with bolus injection thermodilution. Anesthesiology (1999) 1.57
Outcome of ICU treatment in invasive aspergillosis. Intensive Care Med (1996) 1.52
Antithrombin III in patients with severe sepsis: a pharmacokinetic study. Intensive Care Med (2000) 1.49
Cardiac tamponade from misplaced central venous line in pericardiophrenic vein. Arch Intern Med (1988) 1.48
Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis. Blood (1995) 1.47
C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2. Intensive Care Med (1993) 1.45
Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. Crit Care Med (1990) 1.43
Acute renal failure in the medical intensive care unit: predisposing, complicating factors and outcome. Nephron (1991) 1.41
Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. Am J Med (1989) 1.34
Inflammatory mediators in dengue virus infection in children: interleukin-8 and its relationship to neutrophil degranulation. Infect Immun (2000) 1.30
Prediction of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-alpha1-antitrypsin, and lactoferrin compared with clinical variables. Clin Infect Dis (1999) 1.26
Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma. Intensive Care Med (2001) 1.26
Proteolytic inactivation of plasma C1- inhibitor in sepsis. J Clin Invest (1989) 1.22
Peripheral vascular resistance in septic shock: its relation to outcome. Intensive Care Med (1988) 1.20
Interobserver variability in the use of APACHE II scores. Lancet (1999) 1.19
Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness. J Clin Endocrinol Metab (2001) 1.18
Inflammatory mediators in dengue virus infection in children: interleukin-6 and its relation to C-reactive protein and secretory phospholipase A2. Am J Trop Med Hyg (2001) 1.16
Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(-)-inhibitor complexes in sepsis. Blood (1988) 1.15
Accuracy and reliability of APACHE II scoring in two intensive care units Problems and pitfalls in the use of APACHE II and suggestions for improvement. Anaesthesia (2001) 1.10
[Corticosteroid administration for critically ill patients]. Ned Tijdschr Geneeskd (2001) 1.07
Hemodynamic determinants of mortality in human septic shock. Surgery (1986) 1.07
Frequencies of lipopolysaccharide core types in Escherichia coli strains from bacteraemic patients. Microbiology (1994) 1.06
Biventricular performance during volume loading in patients with early septic shock, with emphasis on the right ventricle: a combined hemodynamic and radionuclide study. Am Heart J (1988) 1.04
Plasma lipid peroxides and antioxidants in human septic shock. Intensive Care Med (1991) 1.04
Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock. Semin Thromb Hemost (1998) 1.03
Methylene blue increases myocardial function in septic shock. Crit Care Med (1995) 1.03
International sepsis trial (INTERSEPT): role and impact of a clinical evaluation committee. Crit Care Med (1996) 1.02
Relative adrenal failure in intensive care: an identifiable problem requiring treatment? Best Pract Res Clin Endocrinol Metab (2001) 1.01
Production and characterisation of mouse monoclonal antibodies reacting with the lipopolysaccharide core region of gram-negative bacilli. J Med Microbiol (1988) 1.00
Arginase release from red blood cells: possible link in transfusion induced immune suppression? Shock (2001) 0.99
alpha-atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in plasma as markers of myocardial depression in human septic shock. Crit Care Med (2001) 0.99
Complement activation in patients with sepsis is in part mediated by C-reactive protein. J Infect Dis (1998) 0.98
Diagnostic ultrasound in clinical thyroid investigation. J Clin Endocrinol Metab (1971) 0.96
Blast cell leukaemia associated with IgA paraproteinaemia and Bence Jones protein. Br J Haematol (1970) 0.95
Continuous infusion of lorazepam versus medazolam in patients in the intensive care unit: sedation with lorazepam is easier to manage and is more cost-effective. Crit Care Med (1999) 0.95
Interleukin 8-related neutrophil elastase and the severity of the adult respiratory distress syndrome. Cytokine (1995) 0.94
Cardiac arrest due to oral potassium intake. Intensive Care Med (1988) 0.93
A modified competitive inhibition radioimmunoassay for the detection of C3a. Use of 125I-C3 instead of 125I-C3a. J Immunol Methods (1988) 0.92
Use of glucose-insulin-potassium (GIK) in human septic shock. Crit Care Med (1985) 0.90
Effects of recombinant human growth hormone in patients with severe sepsis. Ann Surg (1992) 0.89
An enzyme-linked immunosorbent assay (ELISA) for the measurement of antibodies to different parts of the gram-negative lipopolysaccharide core region. J Immunol Methods (1985) 0.89
Relation of arterial blood lactate to oxygen delivery and hemodynamic variables in human shock states. Circ Shock (1987) 0.88
The clinical host response to microbial infection in medical patients with fever. Chest (1999) 0.88
Quantification of functional and inactivated alpha 2-macroglobulin in sepsis. Thromb Haemost (1991) 0.87
Distribution of cardiac output, oxygen consumption and lactate production in canine endotoxin shock. Cardiovasc Res (1984) 0.87
Disseminated aspergillosis after near-drowning. Neth J Med (1995) 0.87
Interplay of complement and cytokines in the pathogenesis of septic shock. Immunopharmacology (1993) 0.87
Effect of dopamine vs norepinephrine on hemodynamics in septic shock. Emphasis on right ventricular performance. Chest (1989) 0.87
Binding studies of a monoclonal antibody specific for 3-deoxy-D-manno-octulosonic acid with a panel of Klebsiella pneumoniae lipopolysaccharides representing all of the O serotypes. Infect Immun (1994) 0.87
Diagnostic value of the gallium-67 pulmonary leak index in pulmonary edema. J Nucl Med (1996) 0.87
Initial studies on the administration of C1-esterase inhibitor to patients with septic shock or with a vascular leak syndrome induced by interleukin-2 therapy. Prog Clin Biol Res (1994) 0.87
Arterial and mixed venous blood acid-base balance during hypoperfusion with incremental positive end-expiratory pressure in the pig. Anesth Analg (1991) 0.87
Soluble glucan protects against endotoxin shock in the rat: the role of the scavenger receptor. Shock (1998) 0.87
Systemic coagulation and fibrinolysis in patients with or at risk for the adult respiratory distress syndrome. Thromb Haemost (1997) 0.86
Renal function and oxygen consumption during bacteraemia and endotoxaemia in rats. Nephrol Dial Transplant (1997) 0.85
Leiomyosarcoma of the pulmonary trunk associated with pericardial effusion. Thorax (1974) 0.85
The activation of polymorphonuclear neutrophils and the complement system during immunotherapy with recombinant interleukin-2. Br J Cancer (1992) 0.83
Endotoxin-induced neutrophil activation--the role of complement revisited. Prog Clin Biol Res (1991) 0.83
Plasma endothelin levels are increased during septic shock. Crit Care Med (1992) 0.83
Effects of glucose-insulin-potassium (GIK) on the position of the oxyhemoglobin dissociation curve, 2.3-diphosphoglycerate, and oxygen consumption in canine endotoxin shock. J Surg Res (1983) 0.83
What is the cause of pulmonary oedema after acute myocardial infarction? A case study. Intensive Care Med (1996) 0.83
Maldistribution of heterogeneous coronary blood flow during canine endotoxin shock. Cardiovasc Res (1991) 0.82
Circulating endothelin and nitrate-nitrite relate to hemodynamic and metabolic variables in human septic shock. Shock (1999) 0.82
A pilot study to evaluate the effects of C1 esterase inhibitor on the toxicity of high-dose interleukin 2. Br J Cancer (1994) 0.82
Diversity in lipid A binding ligands: comparison of lipid A monoclonal antibodies with rBPI23. Prog Clin Biol Res (1995) 0.81
Transient increase in interleukin-8 and pulmonary microvascular permeability following aortic surgery. Am J Respir Crit Care Med (1995) 0.81
Studies on the contact system of coagulation during therapy with high doses of recombinant IL-2: implications for septic shock. Thromb Haemost (1991) 0.81
Effects of N-acetylcysteine and terbutaline treatment on hemodynamics and regional albumin extravasation in porcine septic shock. Circ Shock (1990) 0.81
Nonlinear analysis of EEG in septic encephalopathy. Neurol Res (1998) 0.81
Effects of human growth hormone in critically ill nonseptic patients: results from a prospective, randomized, placebo-controlled trial. Crit Care Med (1995) 0.81
Time course and variability of the endocrine and metabolic response to severe sepsis. Surgery (1993) 0.80
Adult respiratory distress syndrome in leptospira icterohaemorrhagiae infection. Intensive Care Med (1985) 0.80
The use of nuclear medicine procedures in the diagnosis of Budd-Chiari syndrome. Clin Nucl Med (1978) 0.80
Computed tomography as an adjunct to chest x-rays of intensive care unit patients. Crit Care Med (1988) 0.80
Protective role of NO in the regional hemodynamic changes during acute endotoxemia in rats. Am J Physiol (1994) 0.79
Systemic and regional hemodynamic changes during endotoxin or platelet activating factor (PAF)-induced shock in rats. Circ Shock (1993) 0.79
Raising the standard of hemodynamic monitoring: targeting the practice or the practitioner? Crit Care Med (1997) 0.79
Use of mucin and hemoglobin in experimental murine gram-negative bacteremia enhances the immunoprotective action of antibodies reactive with the lipopolysaccharide core region. Antonie Van Leeuwenhoek (1986) 0.79
The effect of mild endotoxemia during low arginine plasma levels on organ blood flow in rats. Crit Care Med (2000) 0.79
Ventricular function, hemodynamics, and oxygen consumption during infusions of blood and glucose-insulin-potassium (GIK) in canine endotoxin shock. Circ Shock (1982) 0.79
Organ blood flow and distribution of cardiac output in dopexamine- or dobutamine-treated endotoxemic rats. J Crit Care (1993) 0.79
The fall of cardiac output in endotoxemic rats cannot explain all changes in organ blood flow: a comparison between endotoxin and low venous return shock. Shock (1996) 0.79
Adrenal dysfunction in critical illness: a clinical entity that requires treatment? Curr Opin Anaesthesiol (2000) 0.79
Decreased reflection coefficient as a possible cause of low blood pressure in severe septicaemia. Intensive Care Med (1989) 0.79
Renal function and metabolism during endotoxemia in rats: role of hypoperfusion. Circ Shock (1991) 0.79
Pharmacokinetics of a recombinant amino terminal fragment of bactericidal/permeability increasing protein (rBPI21) after liver surgery in rats and humans. Shock (1998) 0.79
The 67gallium pulmonary leak index in assessing the severity and course of the adult respiratory distress syndrome. Crit Care Med (1996) 0.78
Coagulopathy following major liver resection: the effect of rBPI21 and the role of decreased synthesis of regulating proteins by the liver. Shock (2001) 0.78
Heterogeneity of Escherichia coli J5 vaccines. Lancet (1986) 0.78